Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris

This study has been completed.
Information provided by (Responsible Party):
XBiotech, Inc. Identifier:
First received: November 15, 2011
Last updated: June 5, 2014
Last verified: June 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 5, 2014